Cure Alzheimer's Fund is pleased to see the passage of the 21st Centuries Cures Act in the House of Representatives. The overwhelming bipartisan support for the bill shows the need for legislation to improve the process of getting to cures for life-threatening diseases like Alzheimer's.
Released today, the President's Fiscal Year 2016 Budget includes several important increases for medical research. The National Institutes of Health (NIH) will receive an additional $1 billion, incuding $68 million for the National Institute on Aging. These represent roughly a 1.1% and a 3.3% increase in NIH and NIA's respective budgets.
Senator Ed Markey (D-MA) meets with our Chairman & Co-Founder Jeff Morby. Markey and Morby discuss how Cure Alzheimer's Fund and government are working together to secure more funding for the most promising Alzheimer's research.
On Tuesday, Dec. 9, at 1 p.m. EST, Cure Alzheimer’s Fund hosted a free interactive Alzstream™ webinar about how we are partnering with the U.S. government on Alzheimer’s research. This partnership is an indication of the rising awareness and concern for the Alzheimer’s epidemic.
On Tuesday, June 10, the Senate Appropriations Subcommittee on Labor, Health & Human Services (LHHS) earmarked an additional $100 million for Alzheimer's research in their 2015 fiscal year funding bill.
Cure Alzheimer's Fund is gratified that President Obama has specifically highlighted Alzheimer's disease research to benefit from increased research funding included in the Administration's Fiscal Year 2015 budget proposal.
Washington (November 7, 2013) – As the country commemorates November as National Alzheimer’s Awareness month, Senator Edward J. Markey (D-Mass.) has been announced as the new Senate co-chair of the Bipartisan Congressional Task Force on Alzheimer’s Disease. Senator Markey was co-chair of the Task Force with Rep. Chris Smith (R-N.J.) when he served in the House of Representatives. While in the House, then-Rep. Markey co-authored the National Alzheimer’s Project Act, which mandated the development of a first-ever comprehensive National Plan to Address Alzheimer’s Disease.